GCKR Antibodies

Santa Cruz Biotechnology features a diverse variety of GCKR monoclonal antibodies for studying glucokinase regulatory protein (GCKR) in research applications. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GCKR plays a crucial role in glucose metabolism by regulating the activity of glucokinase, an enzyme that facilitates glucose phosphorylation. The regulation of glucokinase by GCKR is vital for maintaining glucose homeostasis and has significant implications in metabolic disorders, including diabetes and obesity. Research focused on GCKR can reveal important insights about glucose metabolism regulation and potential therapeutic approaches. Understanding GCKR function continues to advance knowledge of metabolic pathways and disease mechanisms. Investigating GCKR expression patterns helps identify its role in different tissues and cellular processes. GCKR research contributes to developing new strategies for treating metabolic conditions. Santa Cruz Biotechnology monoclonal antibodies for GCKR support researchers worldwide in advancing scientific understanding of metabolic regulation and disease treatment.